Gene Products, gag

"Gene Products, gag" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen.

Descriptor ID	D015683
MeSH Number(s)	D12.776.775.330 D12.776.964.775.350 D12.776.964.970.600.850.350
Concept/Terms	Gene Products, gag Gene Products, gag gag Polyprotein Polyprotein, gag gag Polyproteins Polyproteins, gag gag Protein Protein, gag Retroviral Antigen gag Protein Viral gag Proteins Proteins, Viral gag gag Proteins, Viral Gene Product, gag gag Gene Product gag Gene Products gag Antigens Antigens, gag gag Viral Proteins Proteins, gag Viral Viral Proteins, gag gag Gene Related Protein gag Gene Related Protein

Below are MeSH descriptors whose meaning is more general than "Gene Products, gag".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Polyproteins [D12.776.775]
Gene Products, gag [D12.776.775.330]
Viral Proteins [D12.776.964]
Retroviridae Proteins [D12.776.964.775]
Gene Products, gag [D12.776.964.775.350]
Viral Structural Proteins [D12.776.964.970]
Nucleocapsid Proteins [D12.776.964.970.600]
Viral Core Proteins [D12.776.964.970.600.850]
Gene Products, gag [D12.776.964.970.600.850.350]

Below are MeSH descriptors whose meaning is related to "Gene Products, gag".

Below are MeSH descriptors whose meaning is more specific than "Gene Products, gag".

Gene Products, gag
Fusion Proteins, gag-pol
gag Gene Products, Human Immunodeficiency Virus

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Gene Products, gag" by people in this website by year, and whether "Gene Products, gag" was a major or minor topic of these publications.

Bar chart showing 11 publications over 9 distinct years, with a maximum of 2 publications in 2004 and 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1999	1	0	1
2000	1	0	1
2002	1	0	1
2004	1	1	2
2005	0	1	1
2006	0	1	1
2011	0	1	1
2013	0	2	2

Below are the most recent publications written about "Gene Products, gag" by people in Profiles.

Taylor HE, Khatua AK, Popik W. The innate immune factor apolipoprotein L1 restricts HIV-1 infection. J Virol. 2014 Jan; 88(1):592-603.

View in: PubMed
Soliven K, Wang X, Small CT, Feeroz MM, Lee EG, Craig KL, Hasan K, Engel GA, Jones-Engel L, Matsen FA, Linial ML. Simian foamy virus infection of rhesus macaques in Bangladesh: relationship of latent proviruses and transcriptionally active viruses. J Virol. 2013 Dec; 87(24):13628-39.

View in: PubMed
SenGupta D, Tandon R, Vieira RG, Ndhlovu LC, Lown-Hecht R, Ormsby CE, Loh L, Jones RB, Garrison KE, Martin JN, York VA, Spotts G, Reyes-Ter?n G, Ostrowski MA, Hecht FM, Deeks SG, Nixon DF. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. J Virol. 2011 Jul; 85(14):6977-85.

View in: PubMed
Schaubert KL, Price DA, Frahm N, Li J, Ng HL, Joseph A, Paul E, Majumder B, Ayyavoo V, Gostick E, Adams S, Marincola FM, Sewell AK, Altfeld M, Brenchley JM, Douek DC, Yang OO, Brander C, Goldstein H, Kan-Mitchell J. Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope. J Immunol. 2007 Jun 15; 178(12):7756-66.

View in: PubMed
Betzig E, Patterson GH, Sougrat R, Lindwasser OW, Olenych S, Bonifacino JS, Davidson MW, Lippincott-Schwartz J, Hess HF. Imaging intracellular fluorescent proteins at nanometer resolution. Science. 2006 Sep 15; 313(5793):1642-5.

View in: PubMed
Kan-Mitchell J, Bajcz M, Schaubert KL, Price DA, Brenchley JM, Asher TE, Douek DC, Ng HL, Yang OO, Rinaldo CR, Benito JM, Bisikirska B, Hegde R, Marincola FM, Boggiano C, Wilson D, Abrams J, Blondelle SE, Wilson DB. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response. J Immunol. 2006 Jun 01; 176(11):6690-701.

View in: PubMed
Ellenberger D, Wyatt L, Li B, Buge S, Lanier N, Rodriguez IV, Sariol CA, Martinez M, Monsour M, Vogt J, Smith J, Otten R, Montefiori D, Kraiselburd E, Moss B, Robinson H, McNicholl J, Butera S. Comparative immunogenicity in rhesus monkeys of multi-protein HIV-1 (CRF02_AG) DNA/MVA vaccines expressing mature and immature VLPs. Virology. 2005 Sep 15; 340(1):21-32.

View in: PubMed
Luo K, Liu B, Xiao Z, Yu Y, Yu X, Gorelick R, Yu XF. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging. J Virol. 2004 Nov; 78(21):11841-52.

View in: PubMed
Alce TM, Popik W. APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein. J Biol Chem. 2004 Aug 13; 279(33):34083-6.

View in: PubMed
Kan-Mitchell J, Bisikirska B, Wong-Staal F, Schaubert KL, Bajcz M, Bereta M. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope. J Immunol. 2004 May 01; 172(9):5249-61.

View in: PubMed

People

Explore

Similar Concepts

Top Journals